| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |